Learn More
  • Anthony Lopez, Billy Roberts, Donna Heimiller, Nate Blair, Gian Porro, Paul Denholm +10 others
  • 2012
NOTICE This report was prepared as an account of work sponsored by an agency of the United States government. Neither the United States government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information,(More)
Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in B cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro, thereby promoting a B cell-intrinsic break in tolerance. Whereas this defect leads to(More)
gle copies and back issues, when available: $60.00 each. Subscriptions from outside the United States are payable in US currency or full equivalent. Japa-nese yen price is available from our agent: USACO Corporation, 17-12 Hi-gashi-Azabu 2-Chome, Minato-Ku, To-kyo 106-0044, Japan. Subscriptions are accepted on a calendar-year basis only. Periodicals postage(More)
The balance between immune effector cells such as T cells and natural killer cells, and immunosuppressive Treg cells, dendritic, myeloid and monocytic sub-populations in the tumor microenvironment acts to calibrate the immune response to malignant cells. Accumulating evidence is pointing to a role for B cells in modulating the immune response to both solid(More)
Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder frequently associated with systemic autoimmunity, including autoantibody-mediated cytopenias. WAS protein (WASp)-deficient B cells have increased B cell receptor (BCR) and Toll-like receptor (TLR) signaling, suggesting that these pathways might impact establishment of the mature, naive(More)
  • 1